• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

How's The Old New England Region Doing?

Quote








Hey poster(s) #7, #19, and #23. Is this the best response you can do to try to justify your job?

Your silly retorts only confirm the fact that your position is a complete sham. Pathetic.
 








Anonymous said:
Methinks the New England rep doth protest too much. Your region has a reputation for being not needed as you have close to zero access.
Click to expand...

Access is shitty in Boston, and we have an HS model there. The New England Region also has parts of New York and New Jersey where access is fine. Get out a map sometime.
 








Anonymous said:
There aren't any original New England reps left...
Click to expand...

I just met one the other day. She is probally in her late forties, early fifties and selling for somebody else. Said she had to take NN off her resume because she started with Nordisk and people think she is old. She covered all of New England back then. Sad industry when people think your old in your forties and fifties. I'd say, if somebody had good access, bring them back. You know she probally wined and dined all those endos up there.
 




Anonymous said:
I just met one the other day. She is probally in her late forties, early fifties and selling for somebody else. Said she had to take NN off her resume because she started with Nordisk and people think she is old. She covered all of New England back then. Sad industry when people think your old in your forties and fifties. I'd say, if somebody had good access, bring them back. You know she probally wined and dined all those endos up there.
Click to expand...

Your probally write.
 








Anonymous said:
Hey poster(s) #7, #19, and #23. Is this the best response you can do to try to justify your job?

Your silly retorts only confirm the fact that your position is a complete sham. Pathetic.
Click to expand...

Why do you even care?

The only thing that's pathetic are your desperate repeated attempts at proving a moot point.
 




Anonymous said:
I just met one the other day. She is probally in her late forties, early fifties and selling for somebody else. Said she had to take NN off her resume because she started with Nordisk and people think she is old. She covered all of New England back then. Sad industry when people think your old in your forties and fifties. I'd say, if somebody had good access, bring them back. You know she probally wined and dined all those endos up there.
Click to expand...

I don't think age should be the factor here. If this person had good access and can crack open doors with her previous relationships, I say they company should bring her back up there. Physcicians are irritated with all these young folks, anyway. We need to be bringing in people with contacts and experience.
 




Anonymous said:
I don't think age should be the factor here. If this person had good access and can crack open doors with her previous relationships, I say they company should bring her back up there. Physcicians are irritated with all these young folks, anyway. We need to be bringing in people with contacts and experience.
Click to expand...

That's how the device world works. They hire people with connections. Pharma needs to do this as well. So tired of these young brats who are irritating the physicians. They use to be a "novelty" but not anymore.
 












Anonymous said:
Who is the Boston HS chick that is the CONTROL FREAK and a wicked liar to boot? No bargain there man. Chick thinks she she live at the Four Seasons and do wine tasting for a living.
Click to expand...

I think it's Great! In a no-see region like New England, just invite the Docs to see YOU.
See you at the Four Seasons; tablet in hand!
That's what I call.....working smart!
 












Know what's funny? Watching you explain away how Boston had the highest share growth in all three products in 2013 and recognized at POA for it. Must be the stellar selling environment.
 








Anonymous said:
Just a guess, but the SOP always seems to be Payola: speaker's fees , research grants, CME, etc.
Click to expand...

Ya. Its a real bastion of excess up here. What's that? No Harvard appointed doc can be a speaker? And that represents how many of the experts?

And don't forget the oodles of trials being run at our hospitals. Probably can count them using one finger.
 




Top Bottom
Back
Quote